All-In U.S. Push for Vaccine Raises Risk Virus Lingers (Correct)

The U.S. strategy to rely on vaccines and treatments, rather than emphasizing social distancing, masks and testing nationwide, threatens to delay the return to normal life for Americans.

While the U.S. has committed more than $10 billion to develop new shots to fight Covid-19, about half of Americans say they are wary of taking them, according to a Gallup poll reported this month. Meanwhile, any shortfalls in the vaccine program could mean the country will struggle with the virus well into 2023, according to the London-based firm Airfinity Ltd.

At the same time, cases are climbing as the weather cools ...